Armin Ghobadi

17PUBLICATIONS
109CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 05, 2026
Safety and efficacy of allogeneic CD19-directed CAR-T therapy CTX110 in relapsed/refractory B-cell non-Hodgkin lymphoma.

|Apr 24, 2026
Development of Colonic Polyposis in a Woman With Chronic Myeloid Leukemia Treated With Dasatinib.

|Apr 06, 2026
Phase 1 Study of KITE-222, an Autologous CLL-1-Directed CAR T-cell Therapy in Patients with Relapsed/Refractory Acute Myeloid Leukemia.

Naval Daver, James S Blachly, Armin Ghobadi

|May 30, 2025
Phase 1/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed/refractory T-cell malignancies.

Armin Ghobadi, Ibrahim Aldoss, Shannon L Maude

|Jan 30, 2025
Impact of vein-to-vein time in patients with R/R LBCL treated with axicabtagene ciloleucel.

Frederick L Locke, Tanya Siddiqi, Caron A Jacobson

|Nov 22, 2024
Itacitinib for prevention of graft-versus-host disease and cytokine release syndrome in haploidentical transplantation.

Ramzi Abboud, Mark A Schroeder, Michael P Rettig

Pageof 3

Frequent Collaborators

7 joint publications

David Miklos

5 joint publications

Olalekan Oluwole

4 joint publications

Joseph P McGuirk

3 joint publications

Abhinav Deol